Navigation Links
Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy
Date:5/14/2008

New technology from Varian Medical Systems delivers faster image-guided intensity-modulated radiotherapy (IMRT) to target tumors while sparing more

healthy tissue

COPENHAGEN, Denmark and AMSTERDAM, Netherlands, May 14 /PRNewswire-FirstCall/ -- Doctors in Denmark and the Netherlands have successfully carried out Europe's first clinical treatments using advanced RapidArc(TM) technology from Varian Medical Systems (NYSE: VAR). Cancer patients at Copenhagen's Rigshospitalet and Amsterdam's VU University medical center became the first people in Europe to benefit from this advanced form of intensity-modulated radiotherapy (IMRT).

Dr. Svend Aage Engelholm, chief radiation oncologist of the Department of Radiation Oncology at Copenhagen University Hospital (Rigshospitalet), says, "Our first image guided RapidArc treatment went perfectly and the only unusual aspect was that the patient joined the clinical team in a celebratory glass of champagne after treatment. He was certainly aware that this was the first clinical treatment of its kind in Europe." Dr. Engelholm said the actual treatment took just 75 seconds to deliver.

The 60-year-old patient, who is half-way through his scheduled treatment cycle, had been receiving five-field image-guided intensity-modulated radiotherapy (IMRT) and doctors decided to convert his treatment plan to RapidArc, which was commissioned on one of the hospital's Clinac(R) iX linear accelerators earlier in the week. "We knew that we would really be able to reduce the rectal dose to this patient by using RapidArc and, as it turned out, we reduced it by 15 percent," adds Dr. Engelholm. He added that, as of this week, RapidArc would be the hospital's standard treatment fo
'/>"/>

SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis
2. Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate $1 To Accelerate Cancer Research
3. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
4. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
5. Fujifilm and the National Breast Cancer Foundation Provide Free Mammograms as Part of Images of Health Campaign
6. European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics Lung Cancer Drug
7. When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer
8. HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics
9. New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor
10. National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients
11. Sale of Colon Cancer Diagnostic Tool to Czech Republic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...NTON, Mass., Dec. 3 Cali...g provider of tools and services for drug discover...ing Image 4.0 software for IVIS® in vivo imag... than 800 Caliper IVIS systems currently installed...res advanced spectral unmixing tools to enhance fl...
(Date:12/2/2009)...BIA, Md., Dec. 2 Martek ... today that it intends to release the results of i... 16, 2009, at approximately 4:00 p.m. Eastern Time...tek will conduct a conference call to discuss thes...may listen to the call live via webcast by visitin...
(Date:12/2/2009)...EW YORK, Dec. 2 Reportlinker.com a...lable in its catalogue: ,, Neurostimulation - ...ortlinker.com/p0164232/Neurostimulation---A-Global...imulation market stands enthused by the growing ba...age-related diseases such as, Parkinson,s, and Alz...
(Date:12/2/2009)...EW YORK, Dec. 2 Reportlinker.com a...lable in its catalogue: ,, Drug Discovery Tech...Opportunities ,, http://www.reportlinker.com/...date-of-Market-Trends--Opportunities.html ,, D...lement of every pharmaceutical company,s business ...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
...ept. 5 /PRNewswire/ - GenoLogics, a leading develo...for life sciences research,announced today the Com...(TM) Applications Program, and its Geneus product ...he Affymetrix, Inc. (Nasdaq:,AFFX) GeneChip(R) mic...ated,its Geneus solution, built for multiple genom...
...ll review common U.S. laws on research and process...nce solutions, ST. LOUIS, Sept. 5 Sigma-Aldrich ...gazine, will present a Web,conference on laborator...1,p.m. EST. The online conference will review comm...d process laboratories and provide attendees,with ...
...., Sept. 5 A study in the August 2007,issue of Pe...,1,5-anhydroglucitol (1,5-AG) blood test to evalua...o target postprandial hyperglycemia (elevated,afte...cose levels is,important in achieving optimal glyc...ular complications, the leading cause of death in ...
Other Biology Technology:GenoLogics' Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform 2GenoLogics' Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform 3Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies 2Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies 3Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes 2
(Date:12/1/2009)...s have two different feeding strategies. A large ...ng that they are generalist predators feeding on o... Some, however, are "herbivorous". This is not t...of their diets consist of plant-derived matter. Fo...y plants to attract ants, called extra-floral nect...
(Date:12/1/2009)...iNose is pleased to announce the publication of re...ng the efficacy and tolerability of its novel, int...ent of chronic rhinosinusitis with nasal polyps in...ional and European Rhinologic Societies. , Chro...disease that can significantly reduce a patient,s ...
(Date:12/1/2009)...imer,s disease, nerve cell degeneration plays a cr... may possibly be derived from steering the generat...e been published in the current issue of the renow...w years ago, neurogenesis the process of nerve ce... the adult brain. The textbooks asserted that dead...
Breaking Biology News(10 mins):Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2New source discovered for the generation of nerve cells in the brain 2Intensive Dialysis Doesnt Save Lives of the Sickest 59940 1Intensive Dialysis Doesnt Save Lives of the Sickest 59940 2Intensive Dialysis Doesnt Save Lives of the Sickest 59940 3Sex of Twins May Affect Outcomes 59938 1Sex of Twins May Affect Outcomes 59938 2Sex of Twins May Affect Outcomes 59938 3Pitt NIH team find way to protect healthy cells from radiation damage 59936 1Pitt NIH team find way to protect healthy cells from radiation damage 59936 2
...ve shown for the first time that carbon nanotubes ...ue. The new technique could change the way doctors...t a solution of nanotubes into a fracture to promo...sue of the American Chemical Society,s journal Che...ientific society. , The success of a bone graft d...
...it felt the last time you burned your finger on a ...ning pain in your hands or feet all the time and k... , David Fink, M.D.It,s called neuropathic pain, ...d medical conditions, especially diabetes. Drugs h...aused by damage to sensory neurons that transmit p...
... California, San Diego biochemists have developed ...ing mystery: how the same proteins can play differ...ncluding those leading to immune responses and can...re published in the September 16 issue of the jour... a computational approach could represent the intr...
Other Biology News:Nanotubes inspire new technique for healing broken bones 2Nanotubes inspire new technique for healing broken bones 3Scientists use gene transfer technology and common virus to block neuropathic pain in animals 2Scientists use gene transfer technology and common virus to block neuropathic pain in animals 3Scientists use gene transfer technology and common virus to block neuropathic pain in animals 4Scientists use gene transfer technology and common virus to block neuropathic pain in animals 5Computer modeling reveals hidden conversations within cells 2Computer modeling reveals hidden conversations within cells 3
Beagle Serum from Innovative Research
Mouse Anti-Human MBP aa67-74 Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Bovine TROPONIN I (CARDIAC & SKELETAL) Monoclonal Antibody, Unconjugated, Clone C5 from AbD Serotec
X-Gal/IPTG Solution from Bioline
Biology Products: